Eyeing Healthy Vision - ReferencesEyeing Healthy Vision - References

July 24, 2006 Natural Products INSIDER

"Eye Health" References

1. Moeller SM et al. "Overall adherence to the dietary guidelines for Americans is associated with reduced prevalence of early age-related nuclear lens opacities in women." J Nutr. 134, 7:1812-9, 2004. www.nutrition.org

2. Christen WG et al. "Fruit and vegetable intake and the risk of cataract in women."Amer J Clin Nutr. 81, 6:1417-1422, 2005. www.ajcn.org

3. Milton RC et al. "Dietary carbohydrate intake and glycemic index in relation to cortical and nuclear lens opacities in the Age-Related Eye Disease Study."Amer J Clin Nutr. 83, 5:1177-84, 2006. www.ajcn.org

4. Morris MS et al. "Carbohydrate intake and glycemic index in relation to the odds of early cortical and nuclear lens opacities."Amer J Clin Nutr. 81, 6:1411-1416, 2005. www.ajcn.org

5. Xiang H, Pan S, Li S. "Studies on human fetal lens crystallins under oxidative stress and protective effects of tea polyphenols." Yan Ke Xue Bao. 14, 3:170-5, 1998.

6. Gupta SK et al. "Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis." Ophthalmic Res. 34, 4:258-63, 2002. www.karger.com/journals/ore/ore_jh.htm

7. Huang W et al. "Growth inhibition, induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in cultured rabbit lens epithelial cells." Yan Ke Xue Bao. 16, 3:194-8, 2000.

8. " Monograph: Vaccinium myrtillus (Bilberry)." Altern Med Rev. 6, 5:500-4, 2001. www.thorne.com/altmedrev

9. Canter PH, Ernst E. "Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision--a systematic review of placebo-controlled trials." Surv Ophthalmol. 49, 1:38-50, 2004.

10. Kajimoto O. et al. Scient Rep Collect. 19:1, 1998.

11. Yanglongyan S et al. "Clinical observation for Difrarel and visual acuity of school-sged mild myopic children." Intl J Opthamol. 3:567070, 2004.

12. Matsumoto H et al. "Stimulatory effect of cyaniding 3-glycosides on the regeneration of rhodopsin." J Agric Food Chem. 51, 12:3560-3, 2003. http://pubs.acs.org/journals/jafcau

13. Nakaishi H et al. "Effects of black currant anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans." Altern Med Rev. 5, 6:553-62, 2000. www.thorne.com/altmedrev

14. Bagchi M et al. "Antioxidant and anticarcinogenic properties of edible berry anthocyanins." The Original Internist. 10:6-14, 2003.

15. Schonlau F, Rohdewald P. "Pycnogenol for diabetic retinopathy: a review." Int Ophthalmol. 24, 3:161-71, 2001.

16. Spadea L and Balestrazzi E. "Treatment of vascular retinopathy with Pycnogenol." Phytother Res. 15:219-23, 2001.

17. Huang SY et al. "Improved haemorrheological properties by Ginkgo biloba extract (EGb 761) in type 2 diabetes mellitus complicated with retinopathy." Clin Nutr. 23, 4:615-21, 2004. www.harcourt-international.com/journals/clnu

18. Bernardczyk-Meller J et al. "[Influence of EGb 761 on the function of the retina in children and adolescent with long lasting diabetes mellitus--preliminary report.]" Klin Oczna. 106, 4-5:569-71, 2004.

19. Thiagarajan G et al. "Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug." Exp Eye Res. 75, 4:421-30, 2002.

20. Ritch R. "Potential role for Ginkgo biloba in the treatment of glaucoma." Med Hypotheses. 54, 2:221-35, 2000. www.harcourt-international.com/journals/mehy

21. Hirooka K et al. "The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma." Curr Eye Res. 28, 3:153-7, 2004.

22. Gao X, Dinkova-Kostova AT, Talalay P. "Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes and mouse leukemia cells against oxidative damage: The indirect antioxidant effects of sulforaphane." PNAS. 98, 26:15221-6, 2001. www.pnas.org

23. Gao X, Talalay P. "Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage." PNAS. 101, 28:10446-51, 2004. www.pnas.org

24. Evans JR. "Antioxidant vitamins and mineral supplements to slow down the progression of age-related macular degeneration."Cochrane Database Syst Rev, 2:CD000254, 2006. www.cochrane.org

25. Sackett CS, Schenning S. "The age-related eye disease study: the results of the clinical trial." Insight. 27, 1:5-7, 2002.

26. Hogg , Chakravarthy U. "AMD and micronutrient antioxidants." Curr Eye Res. 29, 6:387-40, 2004.

27. Flood V et al. "Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study." Ophthalmology. 109, 12:2272-8, 2002.

28. Wood JP, Osborne NN. "Zinc and energy requirements in induction of oxidative stress to retinal pigmented epithelial cells." Neurochem Res. 28, 10:1525-33, 2003.

29. Kokkinou D et al. "Zinc uptake and storage: the role of fundus pigmentation." Graefes Arch Clin Exp Ophthalmol. May 20, 2005; epub ahead of print.

30. Ayala MN, Soderberg PG. "Vitamin E can protect against ultraviolet radiation-induced cataract in albino rats." Ophthalmic Res. 36, 5:264-9, 2004. www.karger.com/journals/ore/ore_jh.htm

31. Mathew JP, Thomas VC, Thomas I. "Selenite cataract and its attenuation by vitamin E in Wistar rats." Indian J Ophthalmol. 51, 2:161-70, 2003.

32. Karslioglu I et al. "Protective role of intramuscularly administered vitamin E on the levels of lipid peroxidation and the activities of antioxidant enzymes in the lens of rats made cataractous with gamma-irradiation." Eur J Ophthalmol. 14, 6:478-85, 2004.

33. McNeil JJ et al. "Vitamin E supplementation and cataract: randomized controlled trial." Ophthalmology. 111, 1:75-84, 2004.

34. Jacques PF et al. "Long-term nutrient intake and 5-year change in nuclear lens opacities." Arch Ophthalmol. 123, 4:517-26, 2005. http://archopht.ama-assn.org

35. Hegde KR, Varma SD. "Protective effect of ascorbate against oxidative stress in the mouse lens." Biochim Biophys Acta. 1670, 1:12-8, 2004. www.elsevier.nl/locate/bba

36. Zhou JW et al. "[Study of blue light induced DNA damage of retinal pigment epithelium (RPE) cells and the protection of vitamin C.]" Shi Yan Sheng Wu Xue Bao. 36, 5:397-400, 2003.

37. Ohta Y et al. "Short-term ascorbic acid deficiency induced oxidative stress in the retinas of young Guinea pigs." J Biomed Sci. 11, 2:172-8, 2004. www.karger.com/jbs

38. Ohta Y et al. "Prolonged marginal ascorbic acid deficiency induces oxidative stress in retina of guinea pigs." Int J Vitam Nutr Res. 72, 2:63-70, 2002.

39. Valero MP et al. "Vitamin C is associated with reduced risk of cataract in a Mediterranean population." J Nutr. 132, 6:1299-306, 2002. www.nutrition.org

40. Taylor A et al. "Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities." Am J Clin Nutr. 75, 3:540-9, 2002. www.ajcn.org

41. Semba RD, Dagnelie G. "Are lutein and zeaxanthin conditionally essential nutrients for eye health?" Med Hypotheses. 61, 4:465-72, 2003. www.harcourt-international.com/journals/mehy41.

42. Berendschot TT et al. "Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract." Arch Ophthalmol. 120, 12:1732-7, 2002. http://archopht.ama-assn.org

43. Burke JD et al. "Diet and Serum Carotenoid Concentrations Affect Macular Pigment Optical Density in Adults 45 Years and Older."J Nutr. 5, 135:1208-1214, 2005. www.nutrition.org

44. Bone RA et al. "Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans." J Nutr. 133, 4:992-8, 2003. www.nutrition.org

45. Johnson EJ. "Obesity, lutein metabolism and age-related macular degeneration: a web of connections." Nutr Rev. 63, 1:9-15, 2005. www.ilsi.org/publications/reviews.html

46. Nolan J et al. "Macular pigment and percentage of body fat." Invest Ophthalmol Vis Sci. 45, 11:3940-50, 2004. www.iovs.org

47. Hammond BR Jr, Ciulla TA, Snodderly DM. "Macular pigment density is reduced in obese subjects." Invest Ophthalmol Vis Sci. 43, 1:47-50, 2002. www.iovs.org

48. Choi JS et al. "Inhibition of nNOS and COX-2 expression by lutein in acute retinal ischemia." Nutrition. 22, 6:668-71, 2006. http://www.sciencedirect.com/science/journal/08999007

49. Koh HH et al. "Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study." Exp Eye Res. 79:21-7, 2004.

50. Murray I et al. Presented at the annual meeting of the Association for Research in Vision and Ophthalmology in Florida, 2002.

51. Chung H et al. "Lutein Bioavailability Is Higher from Lutein-EnrichedEggs than from Supplements and Spinach in Men". J Nutr 134:1887-1893, 2004.

52. Richer S et al. "Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)." Optometry. 75, 4:216-30, 2004.

53. Bowen PE et al. "Esterification does not impair lutein bioavailability in humans." J Nutr. 132:3668-73, 2002. www.nutrition.org

54. Chung HY, Rasmussen HM, Johnson EJ. "Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men." J Nutr. 134, 8:1887-93, 2004. www.nutrition.org

55. Thomson LR et al. "Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail." Invest Ophthalmol Vis Sci. 43, 11:3538-49, 2002. www.iovs.org

56. Hartmann D et al. "Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin." Am J Clin Nutr. 79, 3:410-7, 2004. www.ajcn.org

57. Yasunori N et al. "The effect of astaxanthin on retinal capillary blood flow in normal volunteers. " J Clin Ther Med. 21, 5:537-42, 2005.

58. Nagaki Y et al. "Effects of astaxanthin on accommodation, critical flicker fusion, and pattern visual evoked potential in visual display terminal workers." J Trad Med. 19:170-3, 2002.

59. Kenji S et al. "Effect of astaxanthin on accommodation and asthenopia - efficacy identification study in healthy volunteers." J Clin Ther Med. 21, 6: , 2005.

60. Nagaki Y et al."The supplementation effect of astaxanthin on accommodation and asthenopia." J Clin Ther Med. 22, 1:41-54, 2006.

61. Nanako T et al. "Effects of astaxanthin on accommodative recovery." J Clin Ter Med. 21, 4:431-6, 2005.

62. Sawaki K et al. "Sports performance benefits from taking natural astaxanthin; characterized by visual acuity and muscular fatigue improvements in humans." RinshoIyaku (J Clin Med: Japan)18, 9:1085-1100, 2002.

63. Nakamura A et al. "Changes in visual function following peroral astaxanthin." JpnJ CLin Opthamol. 58, 6:1051-554, 2004.

64. Ohgami K et al. "Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo." Invest Ophthalmol Vis Sci. 44, 6:2694-701, 2003. www.iovs.org

65. Wu TH et al. "An astaxanthin-containing algal extract attenuates selenite-induced nuclear cataract formation in rat pups." Experimental Biology, 2002.

66. Wu TH et al. "Astaxanthin protects against oxidative stress and calcium-induced porcine lens protein degradation."J Agric Food Chem, 54, 6:2418-23, 2006.

67. Gupta SK et al. "Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study." Nutrition. 19, 9:794-9, 2003. http://www.sciencedirect.com/science/journal/08999007

68. Mohanty I et al. "Lycopene prevents sugar-induced morphological changes and modulates antioxidant status of human lens epithelial cells." Br J Nutr. 88, 4:347-54, 2002. www.cabi-publishing.org/journals/bjn

69. SanGiovanni JP, Chew EY. "The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina." Prog Retin Eye Res. 24, 1:87-138, 2005.

70. Singh M. "Essential fatty acids, DHA and human brain." Indian J Pediatr. 72, 3:239-42, 2005.

71. Desmettre T, Rouland JF. "[Hypothesis on the role of nutritional factors in ocular hypertension and glaucoma.]" J Fr Ophthalmol. 28, 3:312-6, 2005.

72. Niu SL et al. "Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency." J Biol Chem. 279, 30:31098-104, 2004. www.jbc.org

73. Xi ZP, Wang JY. "Effect of dietary n-3 fatty acids on the composition of long- and very-long-chain polyenoic fatty acid in rat retina." J Nutr Sci Vitaminol (Tokyo). 49, 3:210-3, 2003.

74. Elner VM. "Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids." Trans Am Ophthalmol Soc. 100:301-38, 2002.